ABSTRACT
Objective:To investigate the efficacy of tandospirone combined with venlafaxine in the treatment of comorbid anxiety and depression and its effects on neurotransmitters and related factors.Methods:A total of 92 patients with comorbid anxiety and depression who received treatment in the Second People's Hospital of Lishui between June 2019 and June 2020 were included in this study. They were randomly divided into an observation group and a control group ( n = 46/group). The control group was treated with venlafaxine, while the observation group was treated with tandospirone and venlafaxine. Before and after treatment, the scores of Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMD), the levels of 5-hydroxytryptamine, brain-derived neurotrophic factor, nerve growth factor, and adverse drug reactions were compared between the two groups. Results:At 4 and 8 weeks after treatment, HAMA scores in the observation group were (11.39 ± 3.11) points and (8.26 ± 2.18) points, respectively, which were significantly lower than (14.72 ± 3.57) points and (10.46 ± 2.37) points in the control group ( t = 4.77, 4.63, both P < 0.05). At 4 and 8 weeks after treatment, HAMD scores in the observation group were (15.95 ± 2.90) points and (9.33 ± 1.54) points, respectively, which were significantly lower than (17.43 ± 2.87) points and (13.28 ± 2.65) points in the control group ( t = 2.46, 8.74, both P < 0.05). After treatment, 5-hydroxytryptamine, nerve growth factor, and brain-derived neurotrophic factor levels in the observation group were (154.59 ± 45.26) μg/L, (13.62 ± 1.16) ng/L, (28.54 ± 2.33) ng/L, respectively, which were significantly higher than (129.99 ± 48.31) μg/L, (11.98 ± 1.04) ng/L, and (25.69 ± 2.51) ng/L in the control group ( t = 2.52, 7.14, 5.64, all P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups ( χ2 = 0.81, P = 0.369). Conclusion:The adjuvant treatment with tandospirone can markedly improve anxiety and depression and protect neurological function of patients with comorbid anxiety and depression, and is highly safe.
ABSTRACT
Objective To investigate the efficacy and safety of anlotinib combined with PD-1 blockades for patients with advanced epithelial ovarian cancer (EOC). Methods A retrospective study was performed, enrolling 33 patients with advanced EOC who failed standard systematic therapy. All patients were administered with anlotinib combined with PD-1 blockades. The efficacy and safety profile were determined during treatment. Results The objective response rate of the 33 patients was 36.4% (95%CI: 20.4%-54.9%) and the disease control rate of the patients was 81.8% (95%CI: 64.5%-90.0%). The median PFS and OS of the 33-patient cohort were 7.6 months (95%CI: 3.1-12.1) and 19.6 months (95%CI: 15.1-24.1), respectively. The most common treatment-related adverse reactions were fatigue (66.7%), nausea and vomiting (54.5%), hypertension (48.5%), and diarrhea (39.4%). Furthermore, multivariate Cox regression analysis indicated that ECOG performance status and FIGO stage were independent factors for predicting the PFS of the combination regimen for patients with advanced EOC. Conclusion Anlotinib combined with PD-1 blockades preliminarily exhibit satisfactory efficacy and tolerable safety profile for patients with advanced EOC.
ABSTRACT
OBJECTIVE@#To explore the serological feature and molecular mechanism for a case with A307 subgroup of the ABO blood group system.@*METHODS@#Serological assay was carried out to determine the ABO blood group of the proband and his family members. Genotypes for exons 1 to 7 of the ABO gene were determined with sequence-specific primer polymerase chain reaction (SSP-PCR) and direct sequencing. The impact of the variant on the stability of alpha-1,3-N-acetylgalactosaminyltransferase (GTA) was predicted through construction of a 3D molecular model.@*RESULTS@#The proband, his brother and daughter were diagnosed with Aend phenotype by serological analysis. Their ABO genotype was determined as A307/O02, with heterozygous c.467C>T (p.P156L) and c.745C>T (p.R249W) variants identified in exon 7 of the ABO gene. Molecular modeling suggested that the p.R249W variant may alter the number of hydrogen bonds between the amino acids. The protein was predicted to have a decreased Δ Δ G value of thermodynamic stability.@*CONCLUSION@#The p.R249W variant may give rise to the A307 subgroup by reducing the stability of the GTA enzyme, leading to serological features of Aend phenotype.
ABSTRACT
Objective@#To explore blood lead level and associated factors among preschool children in Haikou city,and to provide a reference for early detection and timely intervention of children’s lead poisoning.@*Methods@#Stratified random cluster sampling method was used to select 22 038 children from 23 kindergartens in Haikou city from 2015 to 2018. Blood lead level was examined and a questionnaire survey was conducted.@*Results@#The average blood lead level was 22.45 μg/L, with 22.55 μg/L for boys, 23.33 μg/L for girls, 23.09 μg/L for 3-year-old group, 22.13 μg/L for 4-year-old group, 22.58 μg/L for 5-year-old, and 22.10 μg/L for 6-year-old. On average, about 0.50% of the total children was found of high blood lead level, the prevalence decreased by year during 2015-2018 which was 0.80%, 0.62%, 0.47%, and 0.11%, respectively. The high blood lead rate was 0.45% for boys, 0.57% for girls, 0.46% for 3-year-old, 0.37% for 4-year-old, 0.61% for 5-year-old, and 0.56% for 6-year-old. Hyperactivity, inattention, anorexia, frail disease, stomach ache, pale and anemia was found higher in high lead group and 50~99 μg/L group than those in 0~49 μg/L group. Multivariate logistic regression analysis showed that mother’s occupational exposure to lead was positively correlated with children’s high blood lead level. Frequent toy cleaning and outings were negatively correlated with high blood lead levels in children.@*Conclusion@#The high blood lead level of children is closely related to some factors,such as,their living condition,living habits and so on.Theretore,a regular detection of blood lead should be conducted. Parents should be educated about childhood lead poisoning, as well the need to prevent and intervene in daily life.
ABSTRACT
<p><b>OBJECTIVE</b>To explore the molecular mechanism of a case of ABO discrepancies based on the results of blood group serology.</p><p><b>METHODS</b>Five cases of the two-generation pedigrees were analyzed. ABO genotypes were determined using serological tests. DNA sequence analysis was performed on exon 6, exon 7 and intron 3 of the 5 cases to confirm the genotypes of a proband with B subgroup and 4 family members.</p><p><b>RESULTS</b>There were 3 cases of subgroup AB3 and 1 case of subgroup B3 among the 5 family members. The genotypes were identified as A102/B303 and O02/B303, respectively. B303 differed from B101 by intron 3 point mutation (intron3 + 5G>A).</p><p><b>CONCLUSION</b>The point mutation of intron 3 (intron 3+5G>A) is specific in B303.</p>
ABSTRACT
OBJECTIVE To study the absorption,distribution and excretion of 2-fluorine-6-trifluoromethylpyridine (JJBD) in rats.METHODS [14C] Radioactivity isotope tracing method was used.Male SD rats were ig given a single dose of JJBD 10 and 100 mg·kg-1 (radioactivity:3.7 GBq·kg-1).Concentrations of rat plasma,tissue,feces,urine and bile were determined with a liquid scintillation counting (LSC) analyzer.Toxicokinetics (TK) parameters were fitted using WinNonlin.RESULTS TK parameters of JJBD 10 and 100 mg · kg-1 in male SD rats were as follows:area under the curve (AUC（0-t）) was 22 548±1579 and (203 395±27 586) h·iμg Eq.·L-1,half time (t1/2) was 15.8±1.0 and (14.1±0.9) h,peak time (Tmax) was 4.0±3.0 and (6.0±5.0) h,peak concentration (Cmax) was 1450±355 and (7776±1703) μg Eq.·L-1.JJBD was mainly distributed in fat,livers,kidneys,stomachs and intestinal walls.The concentration of JJBD in most of the tissues reached peak values after 4 h.However,JJBD couldn't be detected in the muscle,thymus gland,brain,gonad or spleen.Excretion rate of JJBD was 43.1％ in urine,29.7％ in feces and 9.97％ in cleaning solution within 0-168 h.JJBD could be excreted through bile at a rate of 28.1％ within 0-72 h.CONCLUSION JJBD can be absorbed immediately and excreted slowly in SD rat.There is no accumulation risk.The distribution of JJBD in vivo is very extensive,but cannot go through the blood-brain barrier.JJBD is mostly excreted through feces and urine.
ABSTRACT
Objective To observe the effect of integrated traditional Chinese and Western medicine and rehabilitation therapy on the recovery of neurological function in patients with acute stroke.Methods 84 patients with acute stroke were randomly selected from January 2014 to November 2016 in our hospital and were randomly divided into observation group and control group,42 cases in each group,the control group were treated with combination of traditional Chinese and Western medicine treatment,the patients in the observation group were given rehabilitation therapy,compared two groups of patients effect of treatment.Results Before treatment,there was no significant difference in FMA,BI and NIHSS scores between the two groups; After treatment,the FMA,BI score of observation group were significantly higher than the control group(P<0.05),NIHSS score was significantly lower than the control group(P<0.05); the observation group patients quality of life significantly higher than that of the control group(P<0.05).Conclusion The combination of traditional Chinese and Western medicine and rehabilitation therapy can significantly improve the patient's limb motor function and overall neurological function,effectively improve the patient's daily life ability and quality of life.
ABSTRACT
Objective To explore the clinical efficacy and value of azo steen,montelukast sodium combined with levocetirizine in the treatment of chronic urticaria. Methods 150 cases with chronic urticaria admitted in department of dermatology of Hubei Zhongshan Hospital were divided into A,B and C group,each group had 50 cases. Patients in group A were received montelukast sodium and levocetirizine treatment,which in group B were received montelukast sodium and azo steen treatment,group C were received above three kinds of drug treatment. Total effective rate,adverse reaction and safety in three groups were observed and compared. Results Total effective rate of group C was significantly higher than A and B group(P<0.05), and the safety of group C were better than A and B group(P<0.05 ),too. The occurrence of adverse reaction in group C was significantly less than that in group A and B (P <0.05 ).Conclusion Azo steen,montelukast sodium combined with levocetirizine has good efficacy in treatment of chronic urticaria. It can relieve itching wheals and other symptoms in a short time,with less adverse reaction.
ABSTRACT
<p><b>OBJECTIVE</b>The purpose of this study was to establish two-dimensional magnetic field finite element analysis model of cup-yoke-type magnetic attachment for optmizing the design of magnetic attachments.</p><p><b>METHODS</b>Because the magnetic field of cup-yoke-type magnetic attachment is stable axial-symmetrical, the authors only analyzed two-dimensional magnetic field of 1/2 section. The Maxwell stress between magnet and keeper was integral analyzed using the finite element method, and the attractive force between magnetic attachments was obtained.</p><p><b>RESULTS</b>Compared the value of calculated attractive force with that of examined, the authors found that the procedure veritably reflected influencing trend of variable factors on attractive force, and the value of former one was 10% less than the later one.</p><p><b>CONCLUSION</b>This procedure can be used in magnetic field calculation of cup-yoke-type magnetic attachments.</p>
Subject(s)
Humans , Computer Simulation , Dental Prosthesis, Implant-Supported , Denture Retention , Finite Element Analysis , Magnetics , Models, Biological , Stress, MechanicalABSTRACT
Objective: To develop titanium posted keeper removable magnetic attachment and to decrease its influence on magnetic resonance imaging(MRI). Methods: Pre fabricated soft magnetic alloy pin cap keeper(PSAPK), casting non precious alloycoping keeper(CNPAK), casting precious alloy coping keeper(CPACK), titanium post keeper(TPK) and titanium post(TP) were prepared and applied on the maxilla of a volunteer, MRI was taken and measured. Results: ①The attachments producing artifacts in MRI from the biggest to the smallest were listed in following rank: PSAPK, CNPAK, CPACK, TPK and TP. ②After removing the keeper from titanium post keeper, the post had no artifact on MRI. ③The artifact was the smallest taken with SE sequence. Conclusion: Titanium post keeper is an effective way to solve the artifact problem and will bring benefits to the patients who need MRI examination of head.